Tourmaline Bio Inc. (TRML)
undefined
undefined%
At close: undefined
21.81
-0.37%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -42.12M -19.70M -47.83M -22.71M -18.16M
Depreciation & Amortization 33.00K 6.00K 623.00K 447.00K 379.00K
Stock-Based Compensation 5.77M 195.00K - - -
Other Working Capital -124.00K 709.00 992.00K 1.51M -85.00K
Other Non-Cash Items 8.41M 12.14M 4.83M 2.23M 959.00K
Deferred Income Tax - - - - -
Change in Working Capital -168.00K 902.00K 2.31M 1.61M -85.00K
Operating Cash Flow -28.08M -6.46M -39.99M -19.21M -17.66M
Capital Expenditures -56.00K -5.07M -2.44M -1.29M -562.00K
Acquisitions - -5.00M - - -
Purchase of Investments -16.60M - -275.88M -158.24M -
Sales Maturities Of Investments 20.50M - 181.93M 26.22M -
Other Investing Acitivies - -5.00K - - -
Investing Cash Flow 3.84M -5.07M -96.39M -133.30M -562.00K
Debt Repayment - - - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 86.25M 19.85M -277.00K - -
Financial Cash Flow 156.72M 19.85M 137.40M 131.12M 36.20M
Net Cash Flow 132.48M 8.32M 1.02M -21.39M 17.98M
Free Cash Flow -28.14M -11.53M -42.42M -20.50M -18.22M